How tumors evade immunotherapy: DDB1 sends PD-L1 into nuclei, driving anti-PD-1 resistance
About
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Subscribe to Blog via Email
Join 86 other subscribers
Bioengineer.org © Copyright 2023 All Rights Reserved.